MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Funding Strategies for Architects (Private Equity, Venture & Risk Capital)
Intermediaries: Risk Capital (Angel, Seed, Venture Capital, SPAC, Strategic Corporate, Private Equity, Banking)
Intermediaries: Hedge Funds
*Hedge Funds (Medical, Biotechnology Focused)
Scopia Capital
Finance & Acquisitions: Scopia
Radius Health, Inc (NASDAQ: RDUS)
Organization & Developments: Radius
Parents
Radius Health, Inc (NASDAQ: RDUS)
Children
2018: Radius Health (RDUS)_seekingalpha.com
2018: Radius Health Earnings Update Strengthens Long-Term Thesisseekingalpha.com
2018: Radius Health: Updates To Thesis - Radius Health, Inc. (NASDAQ:RDUS)
2020: Revisiting Radius Health_seekingalpha.com
2021: Revisiting Radius Health
2022: Radius was recently acquired by Gurnet Point capital and Patient Square Capital.
2022: Reevaluating Radius Health_ seekingalpha.com
Biopharmaceutical company focused on developing and commercializing endocrine therapeutics.
Lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture.
Osteoporosis/Metabolic Disease
Phase 1 clinical studies of BA058 Microneedle Patch, “a short wear-time, transdermal form based on a microneedle technology from 3M Drug Delivery Systems.
The new funds will be used to advance Radius’ current Phase 3 clinical trials of its bone-building injectable drug for the treatment of osteoporosis, BA058
Jumps
*Key People: Radius
Finance & Acquisitions: Radius